Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03969420
Title Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tolero Pharmaceuticals, Inc.

acute myeloid leukemia


Alvocidib + Cytarabine


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.